Skip to main content
. 2017 Nov 17;96(46):e8630. doi: 10.1097/MD.0000000000008630

Figure 4.

Figure 4

Association of thyroid carcinoma patient survival and RASSF1A promoter methylation status by the Kaplan–Meier method. (A) Disease-free survival curves by methylation status of RASSF1A promoter. The number of censored cases methylation and unmethylation was 244 and 242, respectively. (B) The Kaplan–Meier survival analysis of overall survival showing the association between thyroid carcinoma and RASSF1A methylation status. The number of censored cases methylation and unmethylation was 251 and 247, respectively.